Company Profile

SYK insider trades (13 months) →

Today's multi-factor rank: 370 of 466 · see the ranking

Quant500 Scores

Momentum

3.7/10

Value

4.4/10

Growth

4.9/10

Quality

5.3/10

Multifactor

4.6/10

Market and Valuation

Price & Market

Prev Close Price:$280.13

Open:$278.02

Day's Low:$274.38

Day's High:$279.15

Bid / Ask:-

Market Cap:105.53B

Enterprise Value:117.50B

52-Week Range

52-Week Low:$267.00

52-Week High:$392.55

Current position in 52-week range

52w Low-52w High

50-Day Avg:$320.40

200-Day Avg:$334.39

Volume

Volume Today:4,784,872

Avg Volume (3m):2,673,284

Avg Volume (10d):3,838,630

52-Week Change:-27.26%

vs S&P 500, 52 weeks:-

Beta:0.77

Valuation Multiples

PER Trailing:29.08

PER Forward:16.44

PEG Ratio:1.33

Price / Book:4.40

Price / Sales (TTM):4.08

EV / Revenue:4.55

EV / EBITDA:15.93

Dividends

Current yield:1.26%

Annual Dividend Rate:$3.52

Dividend Trailing:$3.48

Yield Trailing:1.24%

5-Year Avg Yield:0.99%

Payout Ratio:36.06%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):25.84B

Gross Profit:16.95B

EBITDA:7.38B

Net Income (TTM):3.73B

Rev Growth (YoY):+9.40%

Earnings Growth (YoY):+44.10%

Quarterly earnings growth (YoY):+44.30%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):-

EPS Forward (Est.):$16.74

Revenue Per Share:$67.50

Cash Per Share:-

Book Value:$62.54

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:3.48B

Total Debt:15.45B

Net Debt (Debt - Cash):11.97B

Debt / Equity:64.39%

Current Ratio:2.16

Quick Ratio:1.08

Cash Flows

Operating Cash Flow:5.53B

Free Cash Flow (FCF):4.11B

FCF Yield (FCF / Market Cap):-

Enterprise Value:117.50B

EV / Revenue:4.55

EV / EBITDA:15.93

Profitability

ROE (Return on Equity):16.51%

ROA (Return on Assets):8.16%

PER Trailing:29.08

PER Forward:16.44

Price / Book:4.40

PEG Ratio:1.33

52-Week Change:-27.26%

S&P 500 change, 52 weeks:+14.80%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$9.46

EPS Forward (Est.):$16.74

PER Forward:-

PEG Ratio:1.33

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$67.50

Cash Per Share:-

Book Value:$62.54

Cash Flows (TTM)

Free Cash Flow:4.11B

Operating Cash Flow:5.53B

EBITDA:7.38B

Total Revenue (TTM):25.84B

Net Income (TTM):3.73B

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:383,573,046

Float (free shares):348,138,568

Short interest (shares):7,643,592

Short % of float:-

Short Ratio (days to cover):3.27

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Stryker Corporation (SYK) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
10-Q	2026-07-31	View filing ↗
8-K	2026-07-30	View filing ↗
8-K	2026-06-26	View filing ↗
SD	2026-05-22	View filing ↗
8-K	2026-05-20	View filing ↗
10-Q	2026-05-11	View filing ↗
8-K	2026-05-08	View filing ↗
8-K	2026-04-30	View filing ↗
8-K/A	2026-04-09	View filing ↗
DEFA14A	2026-03-23	View filing ↗

Company and Executive Profile

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

General Information

Headquarters:United States

City:Portage

Employees:56,000

Sector:Healthcare

Industry:Medical Devices

Website:-

Key Executives

Name	Title	Age	Total pay
Mr. Kevin A. Lobo	Chairman & CEO	60	4.72M
Mr. Spencer S. Stiles	President & COO	48	1.74M
Mr. Preston W. Wells	VP & CFO	48	1.49M
Mr. Viju S. Menon	Group President of Global Quality & Operations	57	1.42M
Mr. J. Andrew Pierce	Group President of MedSurg & Neurotechnology	51	1.73M
Ms. Emily Baculik	VP, Chief Accounting Officer & Corporate Controller	45	-
Mr. Robert C. Cohen	CTO and VP of Global R&D - Joint Replacement	-	-
Ms. Debra S. King	VP and Chief Digital & Information Officer	53	-

You have seen the engine room

Few finance sites let you get this far, and none we know of also shows you where its knowledge ends. If this way of working convinces you, the thing almost nobody catches in time can reach you by email: the big insider buys — executives and major shareholders putting in their own money — the same day they report them to the SEC, with the Form 4 linked. It takes three steps and none of them costs anything: create the account, confirm the email we send you, then switch the alert on in your profile (the icon at the top right). It starts off and it goes off again with the same click. Along the way all three are saved: your simulator portfolios, your personal portfolio and your Academy progress, synced across devices.

No card. No spam.

Stryker Corporation (SYK): Quantitative Analysis

Name: Factor scores for Stryker Corporation (SYK)
Creator: Quant500
License: https://quant500.com/legal

Stryker Corporation (SYK) — Healthcare — Medical Devices. SYK is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, SYK has returned −21.2% against +12.2% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Sep 18, 2026.

SYK ranks 370 of 466 on today's multifactor score, and 47 of the 55 Healthcare companies that score. Its strongest factor is quality (Z 0.19, ranked 147 of 473); its weakest is momentum (Z -0.76, ranked 407 of 497). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	-0.251	370 of 466 ↑2
Momentum	-0.761	407 of 497 =
Value	-0.357	329 of 494 ↑2
Quality	0.194	147 of 473 =
Growth	-0.081	209 of 494 =

Market data

Metric	Value
Price	$275.12
Market Cap	105.53B
P/E	29.08
Revenue (last 12 months)	25.84B
Price / book	4.40
Book value per share	$62.54
52-week range	$267.00 – $392.55
Dividend yield	1.26%
Beta	0.77
Average volume	2,673,284
Shares outstanding	383.57M
Short interest (% of float)	2.08% (as of Aug 31, 2026)

When does SYK report earnings? 12 of its last 12, after the close →

What are SYK insiders doing? 81 transactions filed with the SEC, of them 5 buys and 15 sells, the last one on Aug 21, 2026 →

Data as of Sep 18, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Stryker Corporation (SYK) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Stryker Corporation (SYK): Quantitative Analysis

Factor scores

Market data